Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-02-05 13:38:44
Reporting Period:
Filing Date:
Accepted Time:
2013-02-05 13:38:44
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1311241 Intermolecular Inc IMI Semiconductors & Related Devices (3674) 201616267
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528704 Craig James Hunter Intermolecular, Inc.
3011 North First Street
San Jose CA 95134-2004
Svp Global Sales/marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2013-02-01 3,500 $2.00 26,750 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2013-02-01 3,500 $9.44 23,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-02-01 3,500 $0.00 3,500 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
322,000 2019-02-24 No 4 M Direct
  1. The sale reported was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on May 11, 2012.
  2. The transaction was executed in multiple trades in prices ranging from $9.26 to $9.59, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  3. These shares vest pursuant to the following schedule: Twenty-five percent (25%) of the shares subject to the original option (350,000 shares) vested on the first anniversary measured from January 30, 2009 ("Vesting Commencement Date") and the remaining shares vest in 36 successive equal monthly installments thereafter on each monthly anniversary date of the Vesting Commencement Date, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.